Fast-tracking the use of copper in the NHS to tackle AMR

  22 January 2021

Rory Donnelly, clinical research director of Copper Clothing, discusses the need to fast track copper for use in the NHS as an antimicrobial material in light of the rapid roll out of COVID-19 vaccines.

COVID-19 has pushed the topic of public health to the forefront of people’s minds. From the outset, the question on everyone’s lips was, “when will we get a vaccine?”. Now that has been answered, we have seen COVID-19 vaccines rolled out at record speed, requiring immense collaborative efforts across the medical sector to ensure they can be supplied to the population as quickly and as safely as possible. But other medical innovations have not enjoyed this same experience.

Further reading: Health Europe
Author(s): Rory Donnelly
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed